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nin-angiotensin system blocker independently predicted 
AVR. Moreover, retinal arteriolar diameter independently 
predicted renal function (  = 0.33; p  ! 0.05).  Conclusion: 
CKD narrowed retinal arterioles suggesting an extended ef-
fect of CKD on the cerebral microvasculature. This study 
shows that in CKD patients, renal function, BP status and
renin-angiotensin system blockade independently predict 
AVR as a marker for microvascular damage and that retinal 
microvasculature can predict renal function. 
 Copyright © 2009 S. Karger AG, Basel 
 Introduction 
 Microcirculation is defined by precapillary arterioles 
and small arteries, that is, arteries with diameters  ! 350 
  m  [1] . These vessels regulate the steep decline in blood 
pressure (BP)  [2] . Vascular hypertrophy and arterioscle-
rotic changes in this part of the vasculature have been 
demonstrated to play a prognostic role for cardiovascular 
events  [3–6] . This includes the prevalence and incidence 
of stroke. Moreover, retinal microvascular abnormalities 
are associated with cerebrovascular events  [7] . Common 
abnormalities include microaneurysms, soft and hard 
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 Abstract 
 Background: Chronic kidney disease (CKD) is characterized 
by increased cerebrovascular risk. Retinal vessel analysis 
(RVA) is an accepted measure of the retinal microvasculature, 
mirrors hypertension and cardiovascular morbidity. Epide-
miological studies demonstrate narrower retinal arterioles 
with declining renal function. The effect of CKD on the reti-
nal microcirculation remains uncertain.  Methods: RVA was 
performed in 34 non-diabetic CKD patients and 33 age-
matched volunteers with normal renal function. Retinal pho-
tographs were digitized, vascular lumen diameters mea-
sured and the ratio of retinal arteriolar and venular lumen 
diameters (AVR) calculated. Office blood pressure (BP) was 
measured and cardiovascular risk factors assessed.  Results: 
AVR was lower in CKD patients as compared to age-matched 
volunteers (0.77  8 0.05 vs. 0.86  8 0.06; p  ! 0.05). In particu-
lar, retinal arterioles were narrower in CKD patients as com-
pared to volunteers (169.6  8 20.4 vs. 189.5  8 14.2   m; p  ! 
0.01). In CKD, estimated glomerular filtration rate, BP and re-
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exudates, hemorrhages and vessel tortuosity, beside oth-
ers  [8] . However, evidence is lacking that routine fundus-
copy is of additional value in the management of hyper-
tensive patients  [9] .
 Recently, non-invasive retinal vessel analysis (RVA) 
has received increased attention  [10, 11] . It is highly stan-
dardized by computer-assisted digital measurement of 
the ratio of retinal arteriolar and venular diameters 
(AVR) and has been evaluated in large-scale epidemio-
logical studies  [12–14] . Several of these studies addition-
ally calculated renal function and observed that retinal 
microvascular abnormalities were associated with renal 
dysfunction  [15, 16] . However, no study confirmed these 
epidemiological results in a cohort with chronic kidney 
disease (CKD).
 CKD patients are characterized by an increased car-
diovascular mortality, including an elevated cerebrovas-
cular risk  [17] . Therefore, performing RVA in CKD pa-
tients may help in understanding the link between renal 
insufficiency and elevated cerebrovascular risk. In this 
respect, proteinuria as a marker of microcirculatory dam-
age is of particular interest as proteinuria characterized 
not only the severity of CKD  [18] but, in general popula-
tion studies, was more prominent in subjects with arte-
riolar narrowing  [16] .
 We hypothesized that CKD is accompanied by retinal 
microvascular narrowing and that in CKD patients, pro-
teinuria is independently associated with AVR. To ex-
clude microvascular effects associated with diabetes, we 
focused on non-diabetic subjects. To test our hypotheses, 
we performed RVA in non-diabetic CKD patients and 
age-matched controls with normal renal function.
 Methods 
 In a cross-sectional study, 34 CKD patients and 33 age-matched 
volunteers were included. Additionally, 10 hemodialysis patients 
were included for validation of the accuracy of retinal measure-
ments. Patients and volunteers were recruited from the Klinikum 
rechts der Isar and the Nephrological Clinic Weissenburg. In all 
patients, RVA was performed and renal function and office BP 
were assessed. Research has been carried out in accordance with 
the Declaration of Helsinki (2000) of the World Medical Associa-
tion and has been approved by the local Ethics Committee of the 
institution. Written informed consent was obtained from each 
patient after full explanation of the purpose, nature and risk of all 
procedures.
 Glomerular filtration rate was estimated (eGFR) according to 
the Modification of Diet in Renal Disease (MDRD) in CKD pa-
tients and by the formula of the Mayo Clinics  [19] in controls with 
normal renal function. Proteinuria was assessed in morning spot 
urine by determination of the ration of proteinuria and urinary 
creatinine (PCR). Cardiovascular risk factors were evaluated and 
biological parameters measured according to the recommenda-
tions of the American and European Clinical Practice Guidelines. 
The total number of antihypertensive drugs was recorded, in par-
ticular the use of calcium channel blocker and renin-angiotensin 
system (RAS) blocker. Diabetes mellitus was an exclusion criterion 
for both groups and defined as a fasting blood glucose level of at 
least 6.7 mmol/l or as the use of antidiabetic drugs. The inclusion 
criterion for the CKD group was stage 2–5. For the volunteer 
group, an eGFR  ! 60 ml/min/1.73 m2 was an exclusion criterion. 
Volunteers were selected to achieve an age-matched cohort.
 One trained person measured anthropometric characteristics, 
and the body mass index was calculated. Venous blood samples, 
collected after overnight fasting, were analyzed by standard auto-
mated methods for lipids and blood glucose. Office BP was deter-
mined in the sitting position after a 5-min period of rest (Omron, 
Tokyo, Japan). The values represent the mean of at least three 
measurements.
 One trained person performed the retina measurements. 
Methods used to measure and summarize retinal vessel diameters 
from digitized photographs followed a standardized protocol de-
scribed elsewhere  [10] . In brief, two 30° color retinal photographs 
of the left and two photographs of the right eye were taken at base-
line ( fig. 1 ). They were digitized by a high-resolution scanner with 
standard settings (IMEDOS, Jena, Germany). Graders masked to 
the characteristics of participants used a computer program to 
measure diameters of all arterioles and venules in a specified zone 
surrounding the optic disc. These measurements were combined 
into summary indices – the central retinal arteriolar and venular 
equivalents – which represented the average arteriolar and venu-
lar diameters of that eye, respectively. These were finally ex-
pressed as the retinal AVR. The ratio compensates for possible 
magnification differences between eyes, and an AVR of 1 indi-
 Fig. 1. Retinal photography with RVA. A/V represents AVR. Mea-
surements are performed of all arterioles and venules in a speci-
fied zone surrounding the optic disc. Arterioles are marked in 
red, venules in blue (colors in the online version only). 
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cates that arteriolar diameters are, on average, the same as venular 
diameters in that eye, while a smaller ratio suggests narrower ar-
terioles. The AVR reflects the mean of the four photographs.
 Data are expressed as mean  8 SD or percentages. The un-
paired t test or the Wilcoxon rank sum tests were used, respec-
tively. Differences in frequency were tested by   2 analysis. Asso-
ciation was determined using the Pearson coefficient. Multivari-
ate regression analysis was performed to independent predictors 
for AVR. Data were analyzed using SPSS software (version 14.0). 
All tests were two-sided and a p value of  ! 0.05 was considered 
significant.
 Results 
 The characteristics of the non-diabetic CKD patients 
and age-matched volunteers are presented in  table 1 . The 
cause of CKD was glomerulonephritis in 15 patients, uro-
logical diseases in 9 patients and hypertensive nephropa-
thy in 10 patients. The stages of CKD were distributed as 
follows: 9 patients stage 2, 15 patients stage 3, 7 patients 
stage 4, and 3 patients stage 5.
 AVR was negatively correlated with systolic BP in vol-
unteers (r = –0.46, p  ! 0.05;  fig. 2 ), but not with age (r = 
0.20) and eGFR (r = 0.02). Metabolic factors had no in-
fluence on AVR. Central retinal arteriolar equivalent 
(CRAE) was negatively associated with systolic BP (r = 
–0.38) and diastolic BP (r = –0.45, p  ! 0.05) and positive-
ly associated with eGFR (r = 0.47, p  ! 0.05), but not with 
Table 1. Characteristics of non-diabetic CKD patients and healthy 
age-matched controls
Characteristics CKD 
patients
(n = 34)
Control 
subjects
(n = 33)
Age, years 62.3814.2 61.5810.6
Male gender, % 50 61
BMI, kg/m2 29.487.7 26.388.9
Smoking, % 9 15
eGFR, ml/min/1.73 m2 45.3823.7 86.389.1
Protein-creatinine ratio, mg/g 3888343 –
Glycemia, mmol/l 5.180.7 4.680.7
Cholesterol HDL, mmol/l 55.8815.5 69.3813.8
Cholesterol LDL, mmol/l 128.2850.0 147.9841.4
Systolic BP, mm Hg 131.2817.2 138.4817.1
Diastolic BP, mm Hg 073.6812.1 84.0811.6
Heart rate, bpm 69.3813.4 58.888.1
Antihypertensive drugs, n 2.081.0 –
RAS blocker, % 70 –
CCB, % 41 –
AVR 0.7780.05 0.8680.06
CRAE, m 169.6820.4 189.5814.2
CRVE, m 218.3821.2 228.0814.9
Values represent mean 8 SD or percentages (%).
HDL = High-density lipoprotein; LDL = low-density lipopro-
tein; BP = blood pressure; RAS = renin-angiotensin system;
CCB = calcium channel blocker; CRAE = central retinal arte-
riolar equivalent; CRVE = central retinal venular equivalent. 
 Significance level p < 0.05, significant p values: bold.
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 Fig. 2. Association of systolic BP and AVR in  a CKD patients and  b age-matched volunteers. 
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age (r = –0.11) or any metabolic factor. Central retinal 
venular equivalent (CRVE) was positively associated with 
eGFR (r = 0.46, p  ! 0.05), but not with BP (r = 0.15), age 
(r = –0.03) or any metabolic factor.
 In non-diabetic CKD patients, AVR did not show any 
association with BP (r = 0.08;  fig. 2 ), age (r = 0.19) or eGFR 
(r = 0.03). RAS blockade and PCR were positively associ-
ated with AVR (r = 0.44 and r = 0.29, p  ! 0.01 and p = 
0.08;  fig. 3 ). In contrast, calcium channel blockade was 
not associated with AVR. Neither CRAE nor CRVE 
showed any correlation with BP, eGFR, PCR, age or met-
abolic factors (all p  1 0.05).
 In non-diabetic CKD patients, multiple regression 
analysis showed that age, systolic BP and RAS blockade 
independently predicted arteriolar diameter, whereas 
proteinuria lost its value after adding RAS blockade into 
the model ( table 2 ). Additionally, retinal arteriolar diam-
eter independently predicted eGFR (  = 0.33, p  ! 0.01; 
 table 3 ). 
 Regarding the validity of digitized retinal photo-
graphs, we performed measurement in 10 hemodialysis 
patients and repeated the measurement after 1 week. 
These measurements showed a Pearson correlation of 
0.82 between the first and the second measurement.
 Discussion 
 Retinal arterioles were narrower in non-diabetic CKD 
patients as compared to age-matched controls. In CKD 
patients, eGFR, BP and RAS blockade were independent 
predictors for arteriolar diameter, whereas proteinuria 
showed no relevance. Retinal arteriolar diameter predict-
ed renal function.
 The first major finding was that the retinal vessels 
were narrower in non-diabetic CKD patients as com-
pared to age-matched controls with normal renal func-
tion, which was based on significantly smaller retinal ar-
terioles, resulting in lower AVR in CKD patients. These 
data confirm epidemiological studies demonstrating an 
association between a decline in renal function and low 
AVR  [15, 16] . The latter reflects an elevated cardiovascu-
lar risk  [14] and more specifically, cerebral white matter 
lesions  [20] and the incidence of stroke  [21] . Thus, low 
AVR reveals an elevated cerebrovascular risk in CKD pa-
tients as compared to our control group, which is in line 
with common sense  [22] . Moreover, this suggests that the 
extrarenal vascular alterations in CKD patients are not 
restricted to large artery changes  [23] , but contain micro-
vascular changes.
Table 2. Multiple regression analysis for AVR in non-diabetic 
CKD patients
 p
Gender (1 = male, 2 = female) –0.13 0.37
Age, years 0.18 0.57
eGFR, ml/min/1.73 m2 0.48 0.02
Systolic BP, mm Hg –0.51 0.01
RAS blocker (1 = yes, 2 = no) 0.40 0.03
PCR 0.08 0.80
R2 = 0.30.
Table 3. Multiple regression analysis for the independent predic-
tion renal function (eGFR)
 p
Gender (1 = male, 2 = female) 0.08 0.58
Age, years –0.39 0.01
CRAE, m 0.33 0.02
Systolic BP, mm Hg 0.56 0.001
RAS blocker (1 = yes, 2 = no) –0.21 0.19
PCR –0.19 0.17
R2 = 0.52.
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 Fig. 3. AVR in CKD patients depending on RAS blockade.  * p  ! 
0.05. 
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